Rpo LLC Invests $62,000 in Tilray Inc (NASDAQ:TLRY)

Rpo LLC bought a new stake in Tilray Inc (NASDAQ:TLRY) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 46,814 shares of the company’s stock, valued at approximately $62,000. Tilray accounts for about 0.1% of Rpo LLC’s investment portfolio, making the stock its 25th biggest holding.

Several other institutional investors and hedge funds have also recently bought and sold shares of TLRY. BNP Paribas Financial Markets increased its holdings in shares of Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after buying an additional 1,690,827 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in Tilray during the third quarter worth about $1,348,000. Atria Wealth Solutions Inc. raised its holdings in shares of Tilray by 174.7% in the 4th quarter. Atria Wealth Solutions Inc. now owns 84,516 shares of the company’s stock worth $112,000 after purchasing an additional 53,751 shares during the period. Arizona State Retirement System lifted its stake in shares of Tilray by 9.9% in the 4th quarter. Arizona State Retirement System now owns 261,233 shares of the company’s stock valued at $347,000 after purchasing an additional 23,439 shares in the last quarter. Finally, Swiss National Bank grew its holdings in shares of Tilray by 10.2% during the 4th quarter. Swiss National Bank now owns 1,776,638 shares of the company’s stock worth $2,363,000 after purchasing an additional 164,600 shares during the period. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Stock Performance

Tilray stock opened at $0.65 on Thursday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. Tilray Inc has a one year low of $0.58 and a one year high of $2.97. The stock’s 50 day moving average price is $0.82 and its 200 day moving average price is $1.24. The firm has a market capitalization of $609.48 million, a PE ratio of -2.17 and a beta of 1.88.

Tilray (NASDAQ:TLRY) last announced its earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm had revenue of $210.90 million during the quarter, compared to analysts’ expectations of $216.34 million. The business’s revenue was up 8.7% compared to the same quarter last year. As a group, sell-side analysts expect that Tilray Inc will post -0.2 EPS for the current fiscal year.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lifted their price target on shares of Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a research report on Monday, January 13th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $2.70.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.